IP Library Granted Patent US 11,279,944
Granted Patent B2
US 11,279,944 · App. 16/758,830 · Granted Mar 22, 2022

Of herbicide tolerance to 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors by down-regulation of HPPD expression in soybean

Inventors: Manuel Dubald (Research Triangle Park, NC); Marc Linka (Duesseldorf, DE)
Assignee: BASF AGRICULTURAL SOLUTIONS SEED US LLC
C12N15/8274A01H6/542C12N9/0069C12Y113/11027
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,279,944
App. No.
16/758,830
Granted
Mar 22, 2022
Kind
B2
Abstract

A method for conferring tolerance to a 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor herbicide in a plant includes reducing expression of at least one HPPD enzyme in the plant.

Claims (26)

1. A method for conferring tolerance to a 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor herbicide in a plant, comprising reducing expression of at least one endogenous HPPD enzyme in the plant, wherein the method further comprises expressing a mutant HPPD enzyme, wherein the mutant HPPD enzyme is less sensitive to HPPD inhibitors than the corresponding native HPPD enzyme before mutation.

2. The method according to claim 1 , wherein the mutant HPPD enzyme has the amino acid sequence of SEQ ID NO: 1 with the following amino acid substitutions:

(a) a proline at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1 and a tryptophan at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1;

(b) a serine at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1, a serine at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1, a threonine at the amino acid position corresponding to amino acid position 339 of SEQ ID NO:1, and a glutamine at the amino acid position corresponding to amino acid position 340 of SEQ ID NO:1;

(c) a tryptophan at the amino acid position corresponding to amino acid position 188 of SEQ ID NO:1 and a tryptophan at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1;

(d) a proline at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1, a serine at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1, and a glutamic acid at the amino acid position corresponding to amino acid position 340 of SEQ ID NO:1; or

(e) a proline at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1, a tryptophan at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1, an alanine at the amino acid position corresponding to amino acid position 339 of SEQ ID NO:1, and a glutamine at the amino acid position corresponding to amino acid position 340 of SEQ ID NO:1.

3. The method according to claim 2 , wherein the mutant HPPD enzyme has the amino acid sequence of SEQ ID NO: 16.

4. The method according to claim 1 , wherein the expression of at least one HPPD enzyme in the plant is reduced by silencing one or more endogenous HPPD genes in the plant.

5. The method according to claim 1 , wherein the plant is selected from the group consisting of: maize, sorghum, wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean, sugarbeet, sugarcane, tobacco, barley, and oilseed rape.

6. The method according to claim 1 , wherein the plant is soybean.

7. The method according to claim 6 , wherein the HPPD enzyme is encoded by a nucleic acid having the nucleotide sequence of SEQ ID NO: 89 and/or SEQ ID NO: 90.

8. The method according to claim 6 , wherein the method comprises:

(a) transforming a soybean cell with a DNA construct comprising a RNAi region for inhibiting the expression of one or more endogenous HPPD genes; and

(b) regenerating a transgenic soybean plant from said transformed soybean cell.

9. The method according to claim 8 , wherein the DNA construct comprising a RNAi region for inhibiting the expression of one or more endogenous HPPD genes further comprises a coding region that encodes a mutant HPPD enzyme, wherein the mutant HPPD enzyme mutant is less sensitive to HPPD inhibitors than the native HPPD enzyme before mutation.

10. The method according to claim 9 , wherein the mutant HPPD enzyme has the amino acid sequence of SEQ ID NO:1 with the following amino acid substitutions:

(a) a proline at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1 and a tryptophan at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1;

(b) a serine at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1, a serine at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1, a threonine at the amino acid position corresponding to amino acid position 339 of SEQ ID NO:1, and a glutamine at the amino acid position corresponding to amino acid position 340 of SEQ ID NO:1;

(c) a tryptophan at the amino acid position corresponding to amino acid position 188 of SEQ ID NO:1 and a tryptophan at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1;

(d) a proline at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1, a serine at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1, and a glutamic acid at the amino acid position corresponding to amino acid position 340 of SEQ ID NO:1; or

(e) a proline at the amino acid position corresponding to amino acid position 335 of SEQ ID NO:1, a tryptophan at the amino acid position corresponding to amino acid position 336 of SEQ ID NO:1, an alanine at the amino acid position corresponding to amino acid position 339 of SEQ ID NO:1, and a glutamine at the amino acid position corresponding to amino acid position 340 of SEQ ID NO:1.

11. The method according to claim 9 , wherein the coding region encodes the amino acid sequence set forth in any of SEQ ID NOs: 3-59 or fragments thereof.

12. The method according to claim 9 , wherein the coding region encodes the amino acid sequence set forth in SEQ ID NO: 16 or fragments thereof.

13. The method according to claim 9 , wherein the coding region is a synthetic sequence that has been designed for expression in soybean.

14. A transgenic soybean plant produced by the method of claim 8 .

Assignments (7)
CHANGE OF NAME Recorded Jan 20, 2025
From: BASF AGRICULTURAL SOLUTIONS SEED US LLC
To: BASF AGRICULTURAL SOLUTIONS US LLC
Reel/Frame 069957/0265 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERROR IN THE ASSIGNEE'S CITY PREVIOUSLY RECORDED AT REEL: 058203 FRAME: 0401. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 2, 2021
From: BAYER CROPSCIENCE AG
To: BAYER CROPSCIENCE LP
Reel/Frame 058296/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2021
From: BAYER CROPSCIENCE AG
To: BAYER CROPSCIENCE LP
Reel/Frame 058203/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2020
From: BASF SE
To: BASF AGRICULTURAL SOLUTIONS SEED US LLC
Reel/Frame 052537/0774 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2020
From: DUBALD, MANUEL
To: BAYER CROPSCIENCE LP
Reel/Frame 052537/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2020
From: LINKA, MARC
To: BAYER CROPSCIENCE AG
Reel/Frame 052537/0102 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2020
From: BAYER CROPSCIENCE LP; ATHENIX CORPORATION
To: BASF SE
Reel/Frame 052537/0653 →